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Abstract
The common zoonotic pathogen Campylobacter coli is an important cause of bacterial gastroenteritis worldwide but its
evolution is incompletely understood. Using multilocus sequence type (MLST) data of 7 housekeeping genes from a
national survey of Campylobacter in Scotland (2005/6), and a combined population genetic-phylogenetics approach, we
investigated the evolutionary history of C. coli. Genealogical reconstruction of isolates from clinical infection, farm animals
and the environment, revealed a three-clade genetic structure. The majority of farm animal, and all disease causing
genotypes belonged to a single clade (clade 1) which had comparatively low synonymous sequence diversity, little deep
branching genetic structure, and a higher number of shared alleles providing evidence of recent clonal decent. Calibration
of the rate of molecular evolution, based on within-species genetic variation, estimated a more rapid rate of evolution than
in traditional estimates. This placed the divergence of the clades at less than 2500 years ago, consistent with the
introduction of an agricultural niche having had an effect upon the evolution of the C. coli clades. Attribution of clinical
isolate genotypes to source, using an asymmetric island model, confirmed that strains from chicken and ruminants, and not
pigs or turkeys, are the principal source of human C. coli infection. Taken together these analyses are consistent with an
evolutionary scenario describing the emergence of agriculture-associated C. coli lineage that is an important human
pathogen.
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Introduction
Members of the genus Campylobacter are among the most
common cause of bacterial gastroenteritis worldwide. The species
that are principally responsible for human disease, Campylobacter
jejuni and Campylobacter coli [1], cause sporadic infection [2] and
occasional outbreaks [3] usually associated with consumption of
contaminated meat, poultry, water and contact with animals [4,5].
Although C. coli is responsible for fewer food-borne illnesses than
C. jejuni, the impact of C. coli is still substantial: of approximately
340000 annual cases of campylobacteriosis in the UK and 2.5
million in the US [6,7,8], approximately 10% are caused by C. coli
[9]. Therefore, based upon recent estimates, C. coli infection has an
annual cost of £50 million in the UK [10] and $800 million in the
USA [11] but despite the economic importance of this pathogen,
most Campylobacter research focuses upon C. jejuni.
Multi-locus sequence typing (MLST) is a molecular typing
technique that has enhanced studies of the population structure and
epidemiology of Campylobacter [12]. An MLST scheme has been
developed for C. coli [13,14] which characterizes allelic orthologues
of the same seven housekeeping gene loci as the original C. jejuni
MLST system [12]. The inherent reproducibility of this nucleotide
sequence based method and the ability to compare data from
different laboratories has enabled the assembly of large archives of
isolate genotype data [15] which provide a valuable resource for
analysing the epidemiology and evolution of these organisms.
To date, studies of the genetic structure of C. coli populations have
suggested that there is less genetic diversity than in C. jejuni isolate
collections from a comparable sample frame [13,14,16]. However,
sufficient variation inMLST alleles exists to identify correlation with
the animal host from which the isolate was sampled [17,18] and
recent analyses have exploited this host-genotype relationship to
investigate potential disease reservoirs. By describing spatiotempo-
ral patterns and lineage associations in animal hosts [19,20] and
using computer models for the attribution of clinical isolates to
source [21,22,23,24] these studies consistently link genotypes from
clinical isolates with the greatest probability to ruminant and
especially chicken (55–80% of isolates) sources. In contrast to C.
jejuni, where there is little evidence of deep branching phylogenetic
structure, C. coli is divided into three clades [25]. There is evidence
that the clades are associated with sample source, with clades 2 and
3 more common in environmental waters [26], but little is known
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about the clades, for example when they arose, what is their
ecological significance and, in particular, how they relate to clinical
infection caused by C. coli.
Using isolate genotype data from a national survey, the
Campylobacter MLST project in Scotland - CaMPS (2005/6), we
aimed to investigate the disease causing C. coli by analysing the
genetic structure of isolates from a variety of sources including
clinical infection, farm animals and the environment and using
population genetic techniques to characterise the lineages
associated with human disease. C. coli was studied by investigating
(i) the phylogenetic relationships among isolates (ii) the intrinsic
genetic differences between C. coli and C. jejuni lineages, (iii) the
quantitative attribution of clinical isolates to different sources, and
(iv) the rate of molecular evolution and the time of species and
clade divergence. Taken together, these analyses provide evidence
for an evolutionary scenario that describes the emergence of
clinically important C. coli.
Results
Clinical and potential source isolates
There were 5,674 isolates from confirmed clinical cases of
campylobacteriosis, received from 15 health board regions in
Scotland between July 2005 and September 2006. Of these, 427
isolates were excluded because they comprised mixed cultures,
incomplete typing or other Campylobacter species such as C. lari and
C. upsaliensis. Of the remaining clinical isolates (5247), MLST
confirmed that 4747 were C. jejuni and 500 were C. coli. In addition
to isolates from human disease, a total of 200 C. coli isolates from
samples from potential source populations were typed at 7 loci.
These were augmented with archive data (1023 isolates) from
published sources [13,17,22,26,27,28,29] to give a total of 1223
isolates from potential sources. Isolates were grouped by source/
host animal to give isolate datasets for phylogenetic and attribution
analysis from 98 cattle, 54 sheep, 514 chicken, 380 swine, 110
turkey and 67 riparian (water fowl and environmental waters)
sources (Table S1).
Genetic diversity
There were a total of 451 STs, 103 from clinical isolates and
393 from other sources. The 10 most common STs in clinical (ST-
827, ST-825, ST-1774, ST-855, ST-829, ST-1614, ST-872, ST-
962, ST-828, ST-1773) and non-clinical (ST-827, ST-825, ST-
1068, ST-829, ST-855, ST-854, ST-1101, ST-1614, ST-1017,
ST-962) datasets accounted for 72% and 37% of genotypes
respectively. Two clonal complexes were present, defined as in the
standard definition as groups of STs that share 4 or more alleles in
common with the central genotype. Eighty-one percent and 1% of
clinical isolates belonged to the ST-828 complex and the ST-1150
complexes respectively and 52% and 4% of non-clinical isolates
belonged to these complexes. The remainder of isolates did not
belong to a known clonal complex. The clonal complex structure
within C. jejuni is greater compared to data sets of a similar
magnitude from comparable sources [13], and this allows the
identification of clonal complexes with different levels of host
association [20,30]. Similar association analysis was not possible
for C. coli at the clonal complex level but STs belonging to the ST-
828 complex have previously been recovered from clinical disease
isolates and from agricultural sources [13,17]. There was some
variation in allelic diversity by locus (Table S2) but it was generally
low, with the total number of STs (451) approximately equal to the
number of alleles (410) suggesting that the variation in genotypes
results more from re-assortment of existing alleles than generation
of new ones by point mutation which would give more alleles per
locus. The clinical isolate population had different genetic
properties (lower diversity) with the mean number of alleles per
locus (13) lower than in the non-clinical data (55).
Clonal frame genealogy
The genealogy determined using CLONALFRAME showed a
high degree of genetic structuring in isolates sampled from clinical
infection animal sources and the riparian environment (Figure 1).
The 3-clade structure that has previously been described [25] was
evident. Comparison of genotypes from clinical infection with this
genealogy demonstrated that all of the cases of human C. coli
infection were caused by lineages belonging to clade 1 (Table 1).
Eighty-four percent of STs from clade 1 belonged to the ST-828
clonal complex.
Phylogenetic congruence
ML trees were determined for each of the 7 MLST loci for C.
jejuni and C. coli (clades 1–3), and C. jejuni and C. coli combined
(data not shown). The topology of the trees for C. jejuni sequences
showed no evidence of congruence, with alleles frequently
changing position amongst trees. For the combined C. jejuni/C.
coli trees there was congruence, partitioning alleles in accordance
with species. Similarly, with C. coli there was congruence within
the three clades. Visual representation of congruence indicated
that within C. coli STs, alleles are more likely to be associated with
those from the same clade. Quantitative analysis of congruence
was performed using the SH test on the ML trees for combined C.
coli data, C. jejuni/C. coli, C. jejuni, and the three C. coli clades
Figure 1. CLONALFRAME genealogy of 7-locus MLST data from C. coli genotypes from clinical, animal faeces, food and environmental
samples. STs from farm only (green), riparian only (blue), clinical only (red) and farm and clinical (black) sources are indicated by different colours.
doi:10.1371/journal.pone.0015708.g001
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separately (Figure 2). Within C. jejuni there was no evidence of
congruence with the likelihood values (-ln L) for all of the single
locus trees within the range of -ln L values generated for random
trees (Figure 2B). This suggests extensive recombination. The -ln L
for combined C. jejuni/C. coli trees provided evidence of tree
congruence for aspA, gltA, glyA and tkt (Figure 2C). This is expected
as the likelihood of one single locus tree predicting another is high
when they share a distinct two-species distribution. Within C. coli
the congruence between single locus trees, suggested by ST
restriction within clades, was confirmed with likelihood values for
congruence between competing ML trees outside of the –ln L
values for random trees for all 7 MLST loci. This suggests
relatively low levels of recombination between clades. Analysis
within individual C. coli clades showed no evidence of congruence
indicative of recombination within clades.
Molecular clock estimates of clade divergence
The C. jejuni population from the 3 year longitudinal study [21]
that was used to calibrate the tree contained sufficient levels of
mutation, recombination or coalescence events to estimate the
Table 1. Genotypic diversity of C. coli clades from different
sources.
Clade
Number of
STs Number of STs from each source
Clinical Farm animal Riparian
1 393 103 335 0
2 31 0 0 31
3 27 0 2 25
doi:10.1371/journal.pone.0015708.t001
Figure 2. Maximum likelihood (ML) analysis of congruence in Campylobacter jejuni and Campylobacter coli. The ML tree of each MLST
locus is compared with the ML trees from the other six loci for: (A) C. coli clades 1–3, (B) C. jejuni, (C) C. coli and C. jejuni (D) C. coli clade1, (E) C. coli
clade 2 and (F) C. coli clade 3. The tree congruence likelihood (ln L) range is shown with horizontal bars for each locus (black) and for 200 trees of
random topology (grey) for aspA, glnA, gltA, glyA, pgm, tkt and unc respectively from top to bottom on each graph. If the ln L range falls outside the
range calculated for random trees there is more congruence among the ML trees than expected by chance.
doi:10.1371/journal.pone.0015708.g002
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timescale of the genealogy (Neg), where Ne is the effective
population size and g is the generation length. The rate of
molecular change was analysed using the importance sampler [31]
and the results of the three alternative datasets were merged to
produce a model average over the datasets. There was negligible
uncertainty in the tree topology (Figure 3), and the topology was as
expected from separate analyses [32]. The uncertainty in the scale
bar, which represents uncertainty in the calibration of the
molecular clock, was (2719–9194 years) for a scale bar of length
5000 years. The point estimates for the divergence of the different
Campylobacter lineages were consistent with previous estimates [32]
and placed the divergence of C. coli and C. jejuni at 6429 (95% CI,
6280–6579) years ago with C. coli clade 3 diverging approximately
1684 (95% CI, 1659–1709) years ago and clades 1 and 2 diverging
approximately 1023 (95% CI, 1005–1041) years ago (Table 2).
The traditional method for dating recent bacterial evolution
[33,34] is to calibrate the rate of sequence divergence relative to
the split of E. coli and Salmonella typhimurium which Ochman and
Wilson estimated at 120–160 million years ago (Ma), based on 1%
divergence in the 16S rRNA gene per 50 million years [35]. By
this estimate the C. jejuni-C. coli split would have occurred
approximately 10 Ma [32], very different to the estimate (6479
years) using our method, based on intra-specific variation. By our
estimate, speciation is occurring over thousands rather than
millions of years. The root of the tree was dated at 38,269 years
ago (95% CI 20198–73764) and the speciation rate (l) was 0.054
(95% CI 0.019–0.14) per lineage per 1000 years [36]. Estimates of
mutation rate, m=0.029, (95% CI 0.016–0.053), the transition-
transversion ratio, k=2.86 (95% CI 2.47–3.31), and dN/dS ratio,
v=0.011 (95% CI 0.009–0.014) were in good agreement with
previous estimates for this genus [32]. To enable comparison of
our molecular clock calibration based on intraspecific variation
with other estimates, the time represented by the scale bar in
figure 3 was determined using other calibration methods. With an
empirical estimate, based on published generation times [37,38]
and genomic mutation rates [39] for C. jejuni, the scale bar would
represent a period of 42,200 years (95% CI 2,690–661,000) and
with the Ochman and Wilson method [35] the scale bar would
represent 7.6 My [32].
Attribution to putative source
Isolates from known sources were used to test the limitations of
the attribution model as previously described [22]. Random
subsets of the comparison datasets for all putative source
populations were used for self-assignment. Test sets of 50% of
the swine, ruminant, chicken, turkey and riparian isolates were
assigned to host source based on a reduced training set, and the AI
model assigned them with 94%, 89%, 95%, 92%, 88% probability
to the correct source: swine, ruminant, chicken, turkey and
riparian sources respectively. For each clinical isolate the
probability of assignment to each potential source was calculated
and the sum of these probabilities was used to determine the
percentage of all clinical isolates that are attributed to each source.
The clinical C. coli isolates were attributed to source in the
following percentages: 57% to poultry, 41% to ruminant, 1% to
swine, 0.5% to turkey and 0.5% to riparian sources.
Discussion
The genealogical reconstruction of genotypes from diverse
sources demonstrated the clade structure and revealed that all of
human C. coli disease cases were caused by STs belonging to clade
1. The 3-clade structure, and its relationship to disease, is poorly
understood but for it to arise and be maintained requires
differentiated gene pools. The simplest explanation for this is a
general reduction in the overall level of recombination but there is
evidence of frequent recombination within each clade (Figure 2),
and therefore it is likely that recombinational barriers are involved
in clade divergence. Three broad classes of barrier can be
described, (i) mechanistic barriers - imposed by the homology
dependence of recombination [40] or other factors promoting
DNA specificity such as restriction/modification systems [41]; (ii)
ecological barriers - a consequence of physical separation of
bacterial populations in distinct niches; (iii) adaptive barriers -
Figure 3. Phylogeny of estimated divergence times in the genus Campylobacter using BEAST. Error bars, in grey, associated with each
node indicate relative uncertainty in node height. Calibration of the scale bar was based on intraspecific variation in Campylobacter jejuni and
uncertainty associated with the molecular clock calibration is represented by a 95% CI below the scale bar. Empirical and indirect [35] estimates of the
rate of molecular evolution would calibrate the same scale bar at 42,200 (95% CI 2,690–661,000) and 7,600,000 years respectively.
doi:10.1371/journal.pone.0015708.g003
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implying selection against hybrid genotypes [42]. The relative
importance of these three different classes of barrier is unclear but
evidence from interspecies recombination between C. coli and C.
jejuni [25] is consistent with the involvement of factors such as
physical proximity, a shared vector (bacteriophage) infecting both
lineages, or niche adaptation playing a role.
C. coli, clade 1 has several genetic characteristics that distinguish
it from other lineages within C. coli. First, this clade has relatively
low synonymous sequence diversity in MLST genes (mean Ds of
0.006 per nucleotide) compared to C. jejuni (0.016) and clades 2
(0.008) and 3 (0.013). The sequence diversity is higher than that of
organisms commonly described as genetically monomorphic (Ds of
,0.0002), for example enteric Salmonella Typhi or Yersinia pestis
[43], but is still comparatively low indicating a relatively recent
genetic bottleneck. Second, on a tree based on concatenating
multiple genetic regions from each strain, in this case MLST data,
there is little evidence of deep genetic structure that would indicate
long periods of independent evolution of clade 1 (or clade 2).
Third, there is more evidence of genetic exchange within C. coli
clade 1 as STs often share the same allele at individual MLST loci
and as in other bacterial species, this sharing of the majority of
alleles is strong evidence of recent clonal descent.
The importance of recombination in generating variation also
varies among the clades. The relative importance of the re-
assortment of existing alleles (recombination) and the generation of
new ones (mutation), in producing variation can be provided by
comparison of the number of alleles at each locus, ranging in this
study from 120 for aspA to 221 for pgm, with the number expected
for the number of STs (1441) if point mutation generating novel
alleles were responsible for the diversity (1441/7= 206). If the
observed number of alleles is lower than this expected value then
recombination is involved in generating diversity. Using this
method the ratio of observed to expected alleles was 0.5 for C. coli
clade 1 and 0.7 for C. jejuni compared to 2.6 and 4.9 for clades 2
and 3 respectively. This indicates that recombination is 5–10 times
more important in generating diversity in C. coli clade 1 than in the
other clades. Recent work that uses combined population-genetic
microevolutionary models demonstrates that recombination gen-
erates twice as much diversity as de novo mutation in Campylobacter
and has a fundamental role in the evolution of this genus [32]. Our
findings for C. coli clade 1 are consistent with these results but
demonstrate that the importance of recombination can vary within
subgroups of the same species (clades 2 and 3).
The numerical dominance of clade 1 C. coli genotypes from
clinical disease can be explained, without consideration of intrinsic
differences in the ability to infect humans, as a reflection of the
dominance of isolates from this clade in disease reservoirs and food
chain sources. Like C. jejuni, there are limitations on how well C.
coli lineages can be attributed to source because, while there are
host-associated alleles [17,30], there is also considerable niche
overlap with the same alleles and STs found in isolates from
different farm hosts [20,22]. However, alleles from STs clustered
into clade 1 are distinct from those in clades 2 and 3 and this level
of genetic differentiation allows source attribution. This shows that
poultry and ruminants and not pigs and turkeys (clade 1) or the
riparian environment (the source of most clade 2 and 3 isolates),
are the most likely source of human C. coli infection. This is
consistent with evidence of the source of human C. jejuni infection
[21,22,44]. In evolutionary terms, agriculture is a new niche and
the co-infection of animals including chicken and ruminants by
similar strains, despite the differences in the biology of their
digestive tracts, suggests that this niche has acquired specifically
adapted lineages of bacteria, rather than sharing a common gene
pool with a pre-existing natural reservoir. Agricultural environ-
ments are highly unusual in terms of host diet, genetic and age
structure, density and many other details of habitation. It appears
that this novel niche has been recently colonised by clade 1 C. coli
as indicated not only by evidence of a smaller historical population
size but also by the nature of recently recombined C. jejuni alleles
found in C. coli clade 1. These alleles are typical of those found in
C. jejuni from farm sources and are almost all identical to those
found in the donor species, indicating that the imports occurred
recently enough to have not accumulated mutations [25].
Determining the timescale of the evolutionary divergence of the
three C. coli clades provides a context for understanding the link
between ecological factors, such as the domestication of the host
niche, and the population genetic structure. However, there is
some debate about the rate of bacterial evolution because unlike
multicellular eukaryotes they do not leave a morphologically
informative fossil record and, unlike viruses, they do not mutate
fast enough for evolution of natural populations to be easily
measured in real time. Indirect methods calibrate the molecular
clock in bacteria by cross-referencing events that can be dated. For
example, the common ancestor of mitochondria and their closest
living bacterial relatives [35] or cospeciation (of bacterial
endosymbionts) with invertebrate hosts for which a fossil record
is available [45]. Estimates based on such methods have been
widely used [33,34,46,47] but they can conflict with empirical
approaches that are based on laboratory measurements of
generation lengths and mutation rates [48,49].
Table 2. Estimates of the time of Phylogenetic splits in the genus Campylobacter.
95% CI
Split Point estimate (years) Relative uncertainty (years) Total uncertainty* (years)
fetus – jejuni 38269 36824–39770 20198–73764
lari – jejuni 23713 22830–24630 12499–45597
helveticus – jejuni 17907 17155–18691 9403–34645
insulaenigrae – lari 7614 7252–7994 3977–14825
coli – jejuni 6479 6380–6579 3497–12193
helveticus – upsaliensis 4729 4575–4889 2509–9069
coli (clade3) – coli (clades 1 &2) 1684 1659–1709 903–3145
coli (clade 1) – coli (clade 2) 1023 1005–1041 549–1924
*Total uncertainty in each of the split times including uncertainty in the calibration of the molecular clock based on the intraspecific genetic variation in C. jejuni.
doi:10.1371/journal.pone.0015708.t002
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Dating Campylobacter evolution with reference to indirect
methods for estimating the split of E. coli and S. typhimurium [35],
would place the divergence of the three C. coli clades at
approximately 2.5 million years ago. This is incompatible with
the hypothesis that agriculture played a part in the divergence of
the lineages because modern farming did not begin until around
ten thousand years ago (in the Middle East), and was not common
throughout Europe until much later (5,000–3,000 BC) [50,51,52].
However, the more recent estimate for the divergence of the
clades, based on intra-specific variation in longitudinally sampled
C. jejuni isolates, places the divergence of the C. coli clades at less
than 2,500 years ago. This is consistent with the introduction of
agriculture having had an effect upon the evolution of the genus
Camplylobacter, for example by introducing novel opportunities for
pathogens to expand into new host species and to spread rapidly to
new territories. There are several potential causes for the conflict
between short and long term estimates of bacterial evolution and
the debate continues but an increasing number of studies support
the theory of a far more rapid rate of bacterial evolution
[32,53,54,55]. Furthermore, the impact of agriculture upon
bacterial evolution has been demonstrated in Staphylococcus aureus
where the majority of isolates from chickens are the descendants of
a single human-to-poultry host jump that occurred approximately
38 years ago (range, 30 to 63 years ago) in Poland [56]. This
demonstrates the strong global effect that agriculture can have on
bacterial evolution and may inform understanding of the
population genetic structure of Campylobacter in the context of
relatively rapid evolution.
Taken together the population genetic structure, source
attribution of isolates and molecular clock calibration for clade
divergence are consistent with an evolutionary scenario where a
lineage within the C. coli has diverged into an agricultural niche.
This may be related to intrinsic genetic differences associated
with adaptation and the observation that some C. jejuni strains are
more similar to particular strains of C. coli in gene content than
they are to other strains of C. jejuni [57] supports this, but
genome-wide studies of patterns of exchange are necessary to
investigate the nature of barriers to gene flow and the
consequences of recombination for ecological adaptation. Sub-
types belonging to the agricultural C. coli lineage (clade 1) are
responsible for the majority of human disease. It remains possible
that there are genomic differences associated with pathogenicity
but these are not required to explain the over representation of
this clade among human disease cases. The most likely reason for
the dominance of this clade in human disease is that it is an
agricultural lineage and human disease is directly linked to food
animals in the food chain.
Materials and Methods
Ethics statement
Ethical approval (reference: 05/S0802/151) for the collection of
the samples and information used in this project was obtained
from Grampian Local Research Ethics Committee (Summerfield
house, Aberdeen, UK). This was in accordance with government
agreements for research ethics committees (July 2001) and in
compliance with the standard operating procedures in the UK.
Specimens were collected from all 28 NHS clinical diagnostic
laboratories in Scotland that agreed to participate. Archived
isolate information included submitting laboratory, specimen
number and date of collection. In accordance with Grampian
Local Research Ethics Committee approval, patients were
informed of the survey and had the option to decline. As no
information that would allow identification of the patient was
collected, individual patient consent was not required from
patients that did not decline.
Microbiology
The structured sampling and isolation procedure was carried
out as described previously for the Campylobacter MLST project in
Scotland (CaMPS)[19,20,22,24]. In brief, clinical stool isolates
(5674), animal faeces samples (2644) and food samples (394) were
collected to represent all reported clinical cases of campylobacter-
iosis in the 15 health boards in Scotland (July 2005–September
2006) as well as a wide range of potential sources including
contaminated food, animal faeces and the environment over
several geographical areas and time periods. Twenty-five grams of
food and fresh faecal (mammalian) and ,5 g avian faecal samples
were homogenised (1:9) in Campylobacter enrichment broth [58] and
plated (0.1 ml) onto charcoal cefoperazone deoxycholate (CCD,
CM0739, Oxoid, UK) agar. The presence of Campylobacter was
determined by incubating the remaining enrichment broth
microaerobically (2% H2, 5% O2, 5% CO2, balance N2) 100-ml
volumes of nutrient broth base (Mast, Bootle, UK) with 5% horse
blood, growth supplement (Mast Selectavial SV61), amphotericin
(2 mg/ml), cefoperazone (15 mg/ml) and trimethoprim (10 mg/ml)
at 37uC. After 6–8 h enrichment, two additional antimicrobials
(polymixin B, 2500 IU/litre, and rifampicin, 5 mg/ml) were
added, and the broths were incubated for a further 5 days.
Enrichment broths (0.1 ml) were plated, after 2 and 5 days, on
CCD agar (Oxoid, UK) and incubated microaerobically at 37uC
[59]. Gram Stain, Microscreen latex agglutination (Microgen,
Camberley, UK) and PCR amplification - with primers specific for
either C. jejuni or C. coli pgm genes [12]- were used to
presumptively identify Campylobacter. Individual isolates were stored
at 280uC in nutrient broth with 15% (v/v) glycerol.
Multilocus sequence typing (MLST)
DNA was extracted from isolates recultured microaerobically at
37uC (for 48 h) with a CHELEX resin method (BIO-RAD, USA) as
previously described [22]. A high throughput 7-locus MLST
protocol was used, based upon a 2-phase robotic system for PCR
of template DNA arrays and amplification products using published
primers, reagent concentrations, template purification protocols
and cycle parameters [12,14,58]. This process is described in more
detail elsewhere [20,22]. In brief, following electrophoresis (200 V,
10 min) on agarose gel in 1x TAE buffer (1 mM EDTA, 40 mM
Tris-acetate) and UV visualization, 5 ml of the original PCR
products were precipitated with 20% polyethylene glycol–2.5 M
NaCl [60] and nucleotide sequencing PCRs (2 ml of DNA, 6.98 ml
water, 1.0 ml 5x buffer, 0.02 ml BigDye Terminator v3.1 mix
[Applied Biosystems, UK] and 0.1 mM of primer) were performed
in both directions with cycling parameters as follows: 30 cycles of
96uC for 10 s, 50uC for 5 s, and 60uC for 2 min. Sequencing PCR
products were precipitated, cleaned with 95% ethanol, and
analyzed with an ABI Prism 3730 automated DNA sequencer
(Applied Biosystems, UK). Forward and reverse sequences were
assembled using the Staden suite of computer programs [61] and
allelic orthologs were assigned numbers giving a 7-locus sequence
type (ST). Contemporaneous survey data were augmented with
data from published studies [13,17,22,26,27,28,29] obtained from
the publicly accessible MLST database (http://pubmlst.org), hosted
by the University of Oxford [62].
Overview of population genetic analysis
A variety of analytical approaches were used to describe the
evolutionary history of C. coli. Ancestral relatedness of genotypes
was assessed using CLONALFRAME [63] to construct genealogies
Evolution of a Disease Causing C. coli Clade
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for inference of the C. coli phylogeny. Lineage clonality was inferred
by investigating congruence of maximum likelihood trees [64]. The
timescale of C. coli evolution was calibrated using the phylogenetic
inference package BEAST [65] and previous estimates of the
evolutionary rate in the Campylobacter genus based on longitudinal
sequences sampled within C. jejuni [32]. Source attribution of clinical
genotypes was determined using the Asymmetric Island (AI)
probabilistic genetic attribution model [21].
Ancestral relatedness
The genealogy of the C. coli STs was estimated using a model-
based approach for determining bacterial microevolution: CLO-
NALFRAME [63]. Using this model, clonal relationships are
calculated with improved accuracy compared with standard
phylogenetic inference techniques for recombining bacteria
because the two major sources of allelic polymorphisms (point
mutation and recombination) are distinguished. This model has
been used successfully to distinguish clades within C. coli [25].
Analysis was carried out on all the STs from clinical and non
clinical sources. In each case, 7-locus STs were concatenated and
the program run with a burn-in of 50,000 iterations followed by
50,000 iterations of sampling. The consensus tree represents
combined data from three independent runs with 75% consensus
required for inference of relatedness.
Quantifying clonality
The phylogenetic history of bacteria, evolving according to a
clonal model, will be the same for all loci within a genome if it
represents a single linkage group irrespective of location. The
degree of clonality, therefore, can be estimated by measuring the
degree of congruence between phlyogenetic trees constructed for
different loci from a single genome. This approach has been
employed to compare maximum likelihood (ML) trees describing
multiple loci from the genome of, for example, Borrelia burgdorferi
[64], Neisseria meningitidis [66] and Streptococcus uberis [67]. Twenty-
six genotypes were selected to produce ML trees as in previous
studies [66]. Single locus ML trees were constructed for each locus
of sample groups containing C. jejuni, C. jejuni and C. coli, C. coli (12
STs from each clade), C. coli clade 1, C. coli clade 2 and C. coli clade
3 and the congruence between trees was determined using the
Shimodaira-Hasegawa (SH) test [66,68]. The difference in
congruence log-likelihood (D-ln L) of the tree topologies was
determined and compared for the 7 ML trees. If evolution is
entirely clonal then there should be no significant difference in
phylogenetic congruence. The extent of congruence was tested
further using the randomized test [66,68] by comparing the log
likelihood for the 7 individual locus ML tree topologies with
equivalent values for 200 randomly generated trees of the same
size for each gene. If there is more congruence among the ML
trees than expected by chance alone then the log likelihood values
will fall outside the range calculated for random trees. These
analyses were performed using PAUP* version 4 [69].
The timescale of C. coli evolution
The phylogenetic history of C. coli was reconstructed, in the
context of other species within the genus Campylobacter, for which
similar MLST schemes have been developed [12,14,70]. As
described previously [32], 4 of the loci (glnA, glyA, tkt and uncA) used
in 7-locus STs are common to MLST schemes for all species. STs
for each Campylobacter species, C. fetus (ST-4), C. helveticus (ST-2), C.
insulaenigrae (ST-12), C. lari (ST-6), C. upsaliensis (ST-25) and 3 STs
from C. jejuni (ST-21, ST-257 and ST-2678) and C. coli clades 1
(ST-1132, ST-3177, ST-1245), 2 (ST-3323, ST-3828, ST-3314)
and 3 (ST-3310, ST-3309, ST-2681) were tested to confirm the
absence of interspecies recombination between selected STs using
a permutation test based on the correlation between physical
distance and linkage disequilibrium (LD) [71]. These STs were
analysed using the Bayesian phylogenetic package BEAST [65], a
codon substitution model [72] and the Yule model of speciation
rates [36]. On the timescale of Campylobacter evolution all of the
STs from isolates in this study were effectively sampled at the same
time, therefore there was no data for estimating the rate of
evolutionary change. To account for this, we utilized informative
prior distributions on the evolutionary parameters comprising the
transition-transversion ratio, the dN/dS ratio and the synonymous
mutation rate. The priors were taken from the parameters inferred
from an analysis of a longitudinal sample of C. jejuni collected over
a 3-year period [32] assuming a constant rate of evolution within
the genus Campylobacter.
Source attribution of clinical genotypes
The Asymmetric Island (AI) probabilistic genetic attribution
model [21], was used to characterize the population structure from
the genetic data and assign individual isolates in the test set of
human isolates independently to source using the training data set.
This technique has been used previously [21,22] and the
limitations on the attribution accuracy achievable from a 7-locus
profile have been validated by calculating the probability of
correct ‘self-assignment’ of a randomly selected sub-set of each
host species to the correct origin population [22]. The AI program
was run with 1,000 iterations of burn-in followed by 10,000
iterations of sampling, for probabilistic assignment. The putative
source of 7-locus genotypes from clinical C. coli isolates (500) was
assigned by comparison to datasets comprising genotype data from
contemporaneous host and environmental/food isolates and
genotype data from published sources [13,17,22,26,27,28,29].
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